Literature DB >> 791656

Control mechanism of lymphocyte traffic. Altered distribution of 51Cr-labeled mouse lymph node cells pretreated in vitro with lipopolysaccharide.

A A Freitas, M de Sousa.   

Abstract

The effect of in vitro treatment of mouse lymph node cell populations with lipopolysaccharide (LPS) on their migration in syngeneic recipients was studied. LPS-exposed cells had a decreased lymph node localization and an increased spleen distribution when compared to control untreated cells, after intravenous injection into syngeneic recipients. This effect of LPS on cell traffic was maximal at 24 h and could not be detected at either 1 or 72 h after cell transfer. These changes induced on cell distribution by LPS treatment are interpreted as the consequence of a modified interaction between the circulating lymphocytes and the resident cells within the spleen of the recipients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 791656     DOI: 10.1002/eji.1830060407

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  4 in total

1.  Ecotaxis: the principle and its application to the study of Hodgkin's disease.

Authors:  M D Sousa; M Yang; E Lopes-Corrales; C Tan; J A Hansen; B Dupont; R A Good
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

2.  The effects of complement activation by cobra venom factor on the migration of T and B lymphocytes into rat thoracic duct lymph.

Authors:  C J Spry; J T Lane; A Vyakarnam
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  The nature of hepatic lymphocytic infiltrates in the tropical splenomegaly syndrome.

Authors:  Y M Fakunle; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

4.  TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones.

Authors:  Il-Young Hwang; Chung Park; Kathleen Harrison; John H Kehrl
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.